Fda Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

States that could decide the outcome feel about both candidates. Post Debate Polling from the New York times and Sienna College has this race between Kamala Harris and Donald Trump deadlocked nationally. But its a different story when you zoom in to battleground pennsylvania. Vice president harris is up 4 points among likely voters there, albeit within the margin of error. Well dig deeper into the numbers, including why the share of voters who wanted to learn more about harris before last Weeks Debate have largely remained unconvinced. New Quinnipiac Polling also has the Vice President leading...

investigation. and nothing will ever stop us from keeping america secure. ♪ ♪ >> norah: political showdown. the manhattan district attorney sue is a member of congress to keep republicans from interfering in the donald trump case. a cbs news investigation, how china built its own boeing 737. >> do you feel like they stole an airliner? >> i don't feel that way, i think that is a fact. ♪ ♪ >> norah: our tax series, how you can maximize your refund in a year where many of americans will get less cash back. >> so used to getting something back all of the time, and all of a sudden...

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the...

X4 Pharmaceuticals (XFOR), focused on rare diseases of the immune system, announced Monday that the U.S. Food and Drug Administration or FDA has approved XOLREMDI (mavorixafor) capsules for use in patients 12 years of age and older with WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis).

The FDA granted full approval to tisotumab vedotin for recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.